Clinical trials: Adhesion, Tissue
Symptomatic Vitreomacular Adhesion (VMA)
A Retrospective Chart Review of Patients Treated With Ocriplasmin for Symptomatic VMA
The purpose of this study is to retrospectively review and further characterize anatomic and symptomatic changes over six months immediately following treatment of symptomatic vitreomacular adhesion (VMA) with JETREA®…
- Trial name
- OZONE (NCT02193945)
- Where
- 24 sites in United States
- Volunteers
- 134 people
- Sponsor
- ThromboGenics
Cancer
Study of a Focal Adhesion Kinase Inhibitor in Subjects With Solid Tumors
This study is a Phase I dose escalation study in subjects with solid tumors. Part 1 will identify the maximum tolerated dose (MTD) using a dose-escalation procedure.
- Trial name
- NCT01138033
- Testing
- GSK2256098
- Where
- 10 sites in Australia, France and 1 more
- Volunteers
- 74 people
- Sponsor
- GlaxoSmithKline
Non Hematologic Cancers, Metastatic Cancer
Phase I Dose Escalation Study of VS-4718 in Subjects With Metastatic Non-Hematologic Malignancies
This is a Phase I, open-label, multicenter, dose-escalation trial of VS-4718, a focal adhesion kinase inhibitor, in subjects with metastatic non-hematologic malignancies.
- Trial name
- NCT01849744
- Testing
- VS-4718
- Where
- 5 sites in United States
- Volunteers
- 48 people
- Sponsor
- Verastem, Inc.
Healthy
Adhesion Performance Study of Lidocaine Topical System 1.8% Compared to Generic Lidocaine Patch 5% in Healthy, Adult, Human Subjects
An open label, randomized, two-treatment, two-period, single-dose study evaluating the product adhesion in healthy, adult subjects using ZTlido 1.8% Topical System and a generic Lidocaine Patch 5%
- Trial name
- NCT04319926
- Testing
- lidocaine topical system 1.8%, lidocaine patch 5%
- Where
- United States
- Volunteers
- 24 people, healthy volunteers welcome
- Sponsor
- Scilex Pharmaceuticals, Inc.
Leukocyte Adhesion Deficiency, Type II
Study of ORL-1F (L-fucose) in Patients With Leukocyte Adhesion Deficiency Type II
Study of ORL-1F in Patients With Leukocyte Adhesion Deficiency Type II
- Trial name
- NCT03354533
- Testing
- L-fucose
- Volunteers
- 4 people
- Sponsor
- Orpha Labs
Patients With Thyroidectomy (Scheduled)
Clinical Trial to Evaluate the Efficacy and Safety of Adhesion Barrier Mediclore Versus no Treatment in Patients With Total Thyroidectomy
A randomized, single-blind, multi-center, Phase III clinical trial to evaluate the efficacy and safety of adhesion barrier Mediclore versus no treatment in patients with total thyroidectomy
- Trial name
- NCT02940210
- Testing
- Mediclore® (adhesion barrier)
- Where
- South Korea
- Volunteers
- 172 people
- Sponsor
- CGBio Inc.
Smoldering Multiple Myeloma
A Phase II Study of BI-505 in Smoldering Multiple Myeloma
The purpose of this study is to investigate the effect of BI-505 on tumor burden in patients diagnosed with smoldering multiple myeloma.
- Trial name
- NCT01838369
- Testing
- BI-505
- Where
- Sweden
- Volunteers
- 4 people
- Sponsor
- BioInvent International AB
Adhesions
Evaluation of Bioresorbable Sheet to Prevent Intra-Abdominal Adhesions in Colorectal Surgeries
Study to investigate and determine the difference between the extent and severity of intra-abdominal adhesions in patients where SurgiWrap film was placed compared to patients with no adhesion barrier inserted.
- Trial name
- NCT00902148
- Testing
- Polylactic Acid Sheet
- Where
- Norway
- Volunteers
- 19 people
- Sponsor
- MAST Biosurgery, AG